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This  preliminary  study  examined  the extent  to which  regional  brain  activation  during  a  reward  cue
antisaccade  (AS)  task  was  associated  with  6-month  treatment  outcome  in  adolescent  substance  users.
Antisaccade  performance  provides  a sensitive  measure  of  executive  function  and  cognitive  control,  and
generally improves  with  reward  cues.  We  hypothesized  that  when  preparing  to  execute  an  AS,  greater
activation  in  regions  associated  with  cognitive  and  oculomotor  control  supporting  AS,  particularly  during
reward  cue  trials,  would  be  associated  with  lower  substance  use  severity  at 6-month  follow-up.  Adoles-
cents (n =  14, ages  14–18)  recruited  from  community-based  outpatient  treatment  completed  an  fMRI
reward  cue AS  task  (reward  and  neutral  conditions),  and  provided  follow-up  data.  Results  indicated  that
AS errors  decreased  in reward,  compared  to neutral,  trials.  AS behavioral  performance,  however,  was
not associated  with  treatment  outcome.  As  hypothesized,  activation  in  regions  of  interest  (ROIs)  asso-ntisaccade
eward
ciated  with  cognitive  (e.g.,  ventrolateral  prefrontal  cortex)  and  oculomotor  control  (e.g.,  supplementary
eye  ﬁeld)  during  reward  trials  were  inversely  correlated  with  marijuana  problem  severity  at  6-months.
ROI  activation  during  neutral  trials was  not  associated  with  outcomes.  Results  support  the role  of  moti-
vational  (reward  cue)  factors  to  enhance  cognitive  control  processes,  and  suggest  a  potential  brain-based
correlate  of youth  treatment  outcome.
© 2015  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND. Introduction
Sensitivity to reward and inhibitory control play important roles
n the development and maintenance of substance use behavior
Dawe et al., 2004; Koob and Volkow, 2010). Much less is known
bout brain-based indicators of reward sensitivity and inhibitory
ontrol in relation to substance use treatment outcome. Research
ith treatment-seeking adult substance users suggests that pre-
reatment regional brain activity in response to fMRI tasks assessing
ognitive control is associated with substance use treatment out-
omes (Brewer et al., 2008; Kober et al., 2014). This pilot study of
dolescents recruited from substance use treatment examined the
xtent to which regional brain activation associated with inhibitory
ontrol in a reward cue antisaccade (AS) fMRI task (Geier et al.,
∗ Corresponding author at: WPIC/Pittsburgh Adolescent Alcohol Research Cen-
er, 3811 O’Hara Street, Pittsburgh, PA 15213, United States. Tel.: +1 412 246 5147;
ax: +1 412 246 6550.
E-mail address: chungta@upmc.edu (T. Chung).
ttp://dx.doi.org/10.1016/j.dcn.2015.05.004
878-9293/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article unlicense  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2010; Chung et al., 2011), administered during or shortly after
treatment completion, was correlated with 6-month treatment
outcome.
In research with substance dependent adults, two  fMRI stud-
ies found that greater pre-treatment brain activation related to
cognitive control, particularly in prefrontal regions, was associ-
ated with less substance use over follow-up (Brewer et al., 2008;
Kober et al., 2014). Speciﬁcally, among cocaine dependent adults,
greater pre-treatment regional brain activity during a Stroop color-
word interference task in prefrontal regions, including the anterior
cingulate and ventrolateral prefrontal cortex, was associated with
less cocaine use during treatment (Brewer et al., 2008). Behavioral
Stroop response, however, was not associated with cocaine use
during treatment (Brewer et al., 2008). Further, among cannabis
dependent males, greater pre-treatment Stroop-related activity in
dorsal anterior cingulate cortex was associated with less cannabis
use during treatment; and greater pre-treatment activation in
prefrontal regions, such as ventrolateral prefrontal cortex, was
associated with lower rates of cannabis use over 1-year follow-
up (Kober et al., 2014). These studies of adult substance users
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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uggest an inverse association between pre-treatment regional
ctivation related to cognitive control and substance use outcomes
ver follow-up, and that task-related regional activation, relative
o behavioral response, may  be more strongly related to treatment
utcome.
A sensitive marker of cognitive control of behavior and executive
unctioning is provided by antisaccade (AS) performance (Hutton
nd Ettinger, 2006). Performing an AS requires stopping a prepo-
ent eye movement toward a salient stimulus in favor of a voluntary
ovement to the opposite spatial location (Hallett, 1978; Munoz
nd Everling, 2004). Advantages of using AS to assay cognitive con-
rol include its well-characterized neural circuitry, and the ability
o isolate activity related to response preparation, which is crit-
cal to effective response inhibition (Everling et al., 1998, 2000;
una et al., 2008). Processes supporting AS have a protracted devel-
pment into adolescence, with the ability to consistently execute
S continuing to mature into young adulthood (Luna et al., 2008).
n particular, when executing AS, adolescents, compared to adults,
end to rely more on less mature regions such as dorsolateral pre-
rontal cortex, relative to regions associated with inhibitory control
uch as the cortical eye ﬁelds (Luna et al., 2001). Research indicates
hat youth at high, relative to low, risk for substance involvement
howed poorer AS performance (Habeych et al., 2006), and less acti-
ation of brain regions supporting AS (McNamee et al., 2008). These
ndings suggest possible deﬁcits or delayed maturation in neural
ircuitry supporting AS among high risk youth, and the sensitiv-
ty of AS as a measure of cognitive control. A distributed network
f fronto-subcortical-parietal regions subserves AS, including, for
xample, the frontal eye ﬁeld (FEF), supplementary eye ﬁeld (SEF),
orsolateral and ventrolateral prefrontal cortex (dlPFC and vlPFC),
osterior parietal cortex, anterior cingulate cortex, basal ganglia,
halamus, and superior colliculus (Munoz and Everling, 2004; Luna
t al., 2004; Jamadar et al., 2013).
The performance of tasks that involve strong cognitive control
ver behavior, such as AS, can be improved with the use of reward
r incentive (Hardin et al., 2007; Geier et al., 2010). Adolescents, rel-
tive to adults, tend to be especially sensitive to the motivational
ffects of incentive on AS performance (Padmanabhan et al., 2011).
n the context of reward cues, adolescents tend to show increased
ctivity in striatal regions, whereas adults show greater activa-
ion in OFC (Padmanabhan et al., 2011), suggesting that adolescent
ehavior may  be particularly inﬂuenced by bottom-up reward
rocessing (striatum) in combination with a relatively immature
FC which supports executive processing of reward cues (Geier,
013). Modulation of response inhibition by reward cues has been
xamined using an fMRI reward cue AS task in healthy adolescents
Geier and Luna, 2009; Geier et al., 2010; Padmanabhan et al., 2011),
nd youth with substance use disorder (SUD) (Chung et al., 2011).
hen SUD youth were compared with matched controls using the
eward cue AS task, monetary incentive improved AS performance
mong SUD youth (Chung et al., 2011). Further, when preparing
o execute AS (“preparation” phase) in reward trials, SUD youth,
ompared to controls, showed greater activation in prefrontal and
culomotor control areas associated with effective inhibitory con-
rol. The brain-based mechanisms by which incentives improve
S are thought to involve activation of regions involved in reward
rocessing (e.g., ventral striatum [VS]), which in turn may  enhance
ctivity in regions associated with motor control (e.g., frontal
ye ﬁelds) and executive function (e.g., prefrontal cortex) that
upport AS (Geier, 2013; Geier and Luna, 2009; Harsay et al.,
011).
As a measure of cognitive control, successful AS behavior andreater activation of cognitive control regions supporting AS would
e expected to be associated with better substance use treatment
utcome. Regional brain activation supporting AS, however, may
e more strongly related to treatment outcome than AS behaviorale Neuroscience 16 (2015) 93–100
performance, as found in a study using a Stroop task in treated
adults (Brewer et al., 2008). Further, the use of an incentive (reward
cue) to motivate cognitive control and to improve AS performance
through greater regional activation supporting AS suggests that
regional activation and AS performance during reward (versus neu-
tral) trials will be more strongly associated with better treatment
outcome. That is, an optimized or motivated level of inhibitory con-
trol may  be an important indicator of lower substance use severity
over follow-up among adolescents in substance use treatment.
This pilot study examined response to an fMRI reward cue AS
task administered during or shortly after treatment completion as
a correlate of 6-month outcomes in adolescent substance users.
We predicted, based on the adult literature (e.g., Brewer et al.,
2008), that regional brain activation associated with response inhi-
bition would be more strongly associated with treatment outcome
than AS behavioral performance. In addition, we hypothesized
that when preparing to execute an AS (preparation phase), greater
activation in regions involved in cognitive (e.g., dlPFC, vlPFC) and
oculomotor (e.g., FEF, SEF) control which support AS would be asso-
ciated with lower severity of substance involvement at 6-month
follow-up. We  also predicted that the association between regional
activation and treatment outcome would be stronger for reward,
relative to neutral, trials because reward cues may  motivate and
optimize effective cognitive control in adolescents. Study results
could help to identify neurobiological mechanisms that are associ-
ated with substance use treatment outcomes in youth.
2. Materials and methods
2.1. Participants
Adolescents (ages 14–18) were drawn from a longitudinal,
naturalistic study of youth recruited from community-based inten-
sive outpatient (IOP) treatment for substance use (King et al.,
2009; Chung and Maisto, 2009). Treatment involved group ses-
sions three times per week, with each session lasting three hours.
Recommended duration of IOP treatment was 6–8 weeks. Treat-
ment focused on a goal of abstinence from alcohol and other
non-prescribed drugs, with program content that included relapse
prevention (e.g., exercising inhibitory control over substance use
behavior, coping with urges) and facilitation of 12-step meeting
attendance.
Adolescents included in these analyses (n = 14, 71% male, mean
age = 16.9 [SD = 1.3], 93% Caucasian) had useable fMRI data and
completed a follow-up assessment. Socio-economic status was, on
average, “middle-class” (Hollingshead, 1975; mean = 2.4, SD = 1.3;
range = 1–5, 1 = highest and 5 = lowest). Full scale IQ, determined
by the Wechsler Abbreviated Scale of Intelligence (Psychological
Corporation, 1999), was  in the average range (mean = 106.3,
SD = 10.6). Youth were primarily in intensive outpatient treatment
for marijuana use, with 85.7% meeting criteria for a current (past
6-months) DSM-IV marijuana use disorder (Table 1). All youth
reported at least 1 lifetime DSM-IV marijuana use disorder symp-
tom over the course of the study. A majority (71.4%) of the sample
had a current DSM-IV alcohol use disorder. Prior to treatment, aver-
age frequency of marijuana use was once per week, and average
frequency of alcohol use was once per month (Table 1). The most
common co-occurring lifetime psychiatric conditions included con-
duct disorder (43%), attention deﬁcit hyperactivity disorder (29%),
and major depression (21%).2.2. Procedures
Adolescents in the parent longitudinal study were invited to
participate in an add-on neuroimaging study of brain structure
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Table  1
Sample descriptive statistics (N = 14).
Baseline
Gender (% male) 71.4
Age: mean (SD) 16.9 (1.3)
Race/Ethnicity (% Caucasian) 92.9
Multi-racial (%) 7.1
Socio-economic status: mean (SD) 2.4 (1.3)
Full scale intelligence quotient score: mean (SD) 106.3 (10.6)
Current DSM-IV alcohol use disorder (%) 71.4
Alcohol abuse (%) 64.3
Alcohol dependence (%) 7.1
Current DSM-IV marijuana use disorder (%) 85.7
Marijuana abuse (%) 64.3
Marijuana dependence (%) 21.4
Current DSM-IV nicotine dependence (%) 35.7
aCurrent DSM-IV “other drug” diagnosis (%) 50.0
Other drug abuse (%) 21.4
Other drug dependence (%) 28.6
DSM-IV lifetime psychopathology
Major depression (%) 21.4
Conduct disorder (%) 42.9
Attention deﬁcit hyperactivity disorder (%) 28.6
Frequency of substance use (past 6 months) Baseline 6-month follow-up
Mean (SD) Mean (SD)
Alcohol use 3.4 (1.6) 3.9 (2.1)
Cannabis use 4.9 (3.0) 3.5 (3.0)
DSM-IV symptom count, past 6 months Mean (SD) Mean (SD)
Alcohol abuse and dependence symptoms 1.9 (1.7) 1.5 (1.8)
Marijuana abuse and dependence symptoms 2.7 (2.1) 1.4 (2.2)
Note: SD = standard deviation. Current = past 6-months. Frequency of substance use:
0  = never tried, 1 = no use in past 6 months, 2 = less than once per month, 3 = once per
month, 4 = 2–3 times per month, 5 = once per week, 6 = 2–3 times per week, 7 = 4–6
times per week, 8 = daily. The total number of DSM-IV abuse and dependence symp-
toms met  in the past 6-months was  used for alcohol (maximum of 11 symptoms)
and marijuana (maximum of 10 symptoms).
a “Other drug” refers to substances other than alcohol, cannabis or nicotine. For
“other drug” abuse (none in this category had other drug dependence): n = 1 opi-
ate abuse, n = 1 opiate and cocaine abuse, n = 1 cocaine and hallucinogen abuse. For
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fother drug” dependence: n = 3 opiate dependence (1 also met  criteria for cocaine
buse and sedative dependence), n = 1 cocaine dependence (also had opiate, hallu-
inogen, and stimulant abuse).
nd functioning (Thatcher et al., 2010; Chung et al., 2011, 2013;
lark et al., 2012), and completed comprehensive substance use
nd psychiatric assessments at baseline, 6-months, and 1-year after
aseline as part of the parent project. Baseline assessments were
ompleted, on average, roughly 2 weeks after starting treatment
mean = 16.1 days, SD = 8.4). Analyses focus on 6-month follow-up
i.e., on average, 6 months after the scan day), a period during which
reatment gains are likely to be sustained (King et al., 2009). Two
ases missed the 6-month follow-up, and reported on 6-month
utcome data at the 12-month follow-up. Study protocols were
pproved by the University’s Institutional Review Board. Written
nformed consent (or assent from minor adolescents, and consent
rom the youth’s parent) was obtained prior to initiating study pro-
edures. Youth were compensated for study participation.
Adolescents with a history of signiﬁcant brain injury or other
RI  contraindication (e.g., metal in the body) were excluded from
he neuroimaging protocol. Youth were scanned, on average, 6
eeks (mean = 46.4 days, SD = 14.1) after starting IOP. Most adoles-
ents (8 out of 14) were still in IOP at the time of the scan; 3 had com-
leted treatment (scans were completed within 2 weeks of com-
leting treatment for these 3 cases), 2 adolescents were in aftercare
t the time of the scan (1 was in aftercare for 1 week prior to the
can, the other was in aftercare for 4 weeks prior to the scan), and 1
ropped out after attending treatment for 1 month (and 3 days prior
o the scan). Thus, scans were done after completion or dropout
rom the index treatment episode for 6 of the 14 cases (althoughFig. 1. fMRI antisaccade in the context of reward task: “incentive cue”, “preparation”
and  “response” epochs.
2 of these 6 cases continued in aftercare). Follow-up occurred, on
average, 6 months after the scan day. The current analyses included
a subset of cases (n = 9 overlapping cases) from an earlier report that
compared SUD youth with healthy controls (Chung et al., 2011). The
prior report required cases to be matched to controls on sex and
age, whereas no such matching was  needed here. In preparing for
the scan session, youth were instructed to abstain from alcohol and
illicit substance use for at least 24 h prior to scanning. No adolescent
included in the analyses reported substance use <24 h prior to the
scan. Average number of days since last alcohol use prior to scan
was 35.6 (SD = 41.0), and for marijuana was 67.2 days (SD = 83.1).
2.3. Measures of substance use and psychopathology
Data on substance use and psychopathology were obtained
at each assessment by highly trained interviewers. Participants
reported on frequency of alcohol, marijuana, tobacco, and other
substance use in the past 6-months on a 9-point scale (0 = never
tried to 8 = daily use). A Time Line Follow Back (Sobell and Sobell,
1995) was used to assess daily substance use at baseline (past 30
days) and on the scan day (covering the interval since the baseline
assessment). The Structured Clinical Interview for DSM-IV SUDs
(SCID; First et al., 2002), adapted for adolescents, with good reli-
ability and concurrent validity (Martin et al., 2000), was used to
assess the presence and age at onset and offset (to the nearest
month) of SUD symptoms and diagnoses at each assessment. For
cases that missed the 6-month assessment, report of SUD symp-
toms was  collected since the baseline assessment at the 12-month
follow-up, with ages of onset and offset coded to the nearest month,
to determine symptom count over 6-month follow-up. DSM-IV
Axis I psychopathology (e.g., conduct disorder) was evaluated using
the adolescent version of the Schedule for Affective Disorders and
Schizophrenia (K-SADS: Kaufman et al., 1997), which has demon-
strated good inter-rater reliability (Clark et al., 1997).
2.4. fMRI reward cue antisaccade (AS) task
A fast-event related design was used to assess reward cue effects
on activity unique to each epoch (i.e., cue, preparation, response
execution) of the AS task (Geier et al., 2010; Chung et al., 2011).
At the beginning of each AS trial, participants ﬁrst viewed (1.5 s)
either (1) a ring of green dollar bill signs ($) around a central white
ﬁxation cross as a cue for reward trials, or (2) an equivalently sized,
isoluminant ring of blue pound signs (#) around the ﬁxation cross
for neutral trials (see Fig. 1). The ring then disappeared, and a red
9 gnitiv
ﬁ
p
u
P
p
c
t
“
i
p
o
o
a
(
j
i
p
a
i
t
w
i
r
6
p
p
c
(
n
w
c
a
t
p
c
o
i
2
s
m
(
m
s
M
o
t
d
p
u
p
v
q
s
i
a
w
v
m
e
r6 T. Chung et al. / Developmental Co
xation cross was displayed for 1.5 s signifying that an AS is to be
erformed. Finally, a peripheral target (yellow dot) appeared at an
npredictable horizontal location (±3◦, 6◦, and 98◦ visual angle).
articipants were instructed to look at the mirror location (i.e.,
erform an antisaccade) during this time (1475 ms).
The AS task is a compound trial with an invariant sequence of
omponents (i.e., motor response always follows response prepara-
ory period). Thus, we included approximately 30% partial or
catch” trials, randomly inserted, in addition to jittered inter-trial
ntervals (Ollinger et al., 2001a,b) in order to deconvolve trial com-
onents. Two catch trial variants were presented and consisted
f the trial terminating after either (1) the incentive cue (circles
f “$” or “#”) (i.e. no response preparation or cue to perform an
ntisaccade) or (2) when the response preparation period ended
red ﬁxation cross) (i.e. no peripheral target was presented). A
ittered ﬁxation period of 1.5, 3, or 4.5 s (randomly inserted), dur-
ng which time subjects simply ﬁxated on a central white cross
resented on a black background, was included between all tri-
ls, compound and partial. Inclusion of partial trials and jittered
nter-trial ﬁxations allowed activity unique to each component of
he task to be estimated independently (i.e., activity associated
ith response preparation can be estimated uniquely from reward
mage processing and motor processing).
The protocol included 14 complete reward trials, 6 partial
eward trials (3 of each variant), 14 complete neutral trials, and
 partial neutral trials (3 of each variant) in each run. Trials were
seudorandomized across runs. Each run lasted 5 min  9 s and was
resented 4 times for a total of 56 complete reward trials and 56
omplete neutral trials. Participants were told that they could “win”
i.e., receive a “reward”) up to $10 for correct AS performance, with
o monetary loss (i.e., no “punishment” for incorrect response), and
ere told to try to obtain the maximum amount. For the reward
ondition, the value of any single correct response was intention-
lly kept ambiguous to prevent participants from keeping a running
otal of earnings during the task. No feedback was provided to
articipants on AS performance. Participants who demonstrated
ompliance with the task received the full $10 “reward” at the end
f the imaging session regardless of performance. All participants
n the sample complied with the task.
.5. Eye tracking
Participants were ﬁrst oriented to the AS task outside of the
canner to ensure that they were able to perform the task. Eye
ovements were monitored in the scanner, and scored off-line
Geier et al., 2010; Chung et al., 2011). In the scanner, eye move-
ents were monitored using a long-range optics eye-tracking
ystem (Model 504LRO, Applied Science Laboratories, Bedford,
A), which recorded eye position by pupil-corneal reﬂection
btained by a relay mirror mounted on the head coil with a resolu-
ion of 0.5◦ of visual angle. Simultaneous video monitoring provided
ata on task compliance. At the beginning of the session, a 9-
oint calibration procedure was performed. Stimuli were presented
sing E-prime (Psychology Software Tools, Inc., Pittsburgh, PA),
rojected onto a ﬂat screen positioned behind the magnet. Subjects
iewed the screen using a mirror mounted on a standard radiofre-
uency head coil. Eye movements were scored off-line using ILAB
oftware (Gitelman, 2002) and in-house scoring programs written
n MATLAB (Mathworks, Inc.) that calculated the direction, latency,
nd accuracy of responses.
Correct responses on the AS task were deﬁned as those in
hich the ﬁrst eye movement during the saccade epoch with
elocity greater than or equal to 30◦/s (Gitelman, 2002) was
ade toward the mirror location of the peripheral cue and
xtended beyond a 2.5◦/visual angle from central ﬁxation. Incor-
ect responses occurred when the ﬁrst saccade during the saccadee Neuroscience 16 (2015) 93–100
epoch was  directed toward the peripheral stimulus and exceeded
the 2.5◦/visual angle central ﬁxation zone. Trials in which no eye
movements were generated, or in which the tracker lost ﬁxation,
were excluded from analyses. Prosaccade errors were consistently
followed by movement to the appropriate location, indicating that
instructions were understood, but the reﬂexive saccade was not
effectively inhibited (cf. Velanova et al., 2008).
Behavioral variables included correct and incorrect AS laten-
cies and errors in inhibitory response on rewarded and neutral
trials. Sensitivity to reward on this task was  indicated primarily
by reduced inhibitory errors, and secondarily by shorter latency to
correct AS, during reward compared to non-reward (neutral) trials
(Hardin et al., 2007; Geier et al., 2010).
2.6. Image acquisition
Imaging data were acquired using a Siemens 3T Allegra Scan-
ner. A gradient-echo echo-planar imaging sequence sensitive to
blood oxygenation level dependent (BOLD) contrast (T2*) was  used.
Acquisition parameters were TR = 1.5 s TE = 25 ms,  ﬂip angle = 70◦,
64 × 64 acquisition matrix with ﬁeld of view 20 cm × 20 cm.
Twenty-nine 4 mm-thick axial slices with no gap were collected,
aligned to the anterior and posterior commissure (AC-PC line), gen-
erating 3.125 mm × 3.125 mm × 4 mm voxels, which covered the
entire cortex and most of the cerebellum. A series of magnetization-
prepared rapid gradient echo (MPRAGE) images were acquired.
2.7. fMRI data analysis
Preprocessing of the functional data followed standard tech-
niques. Brieﬂy, these included despiking using AFNI’s 3dDespike
and slice timing correction. Mean relative motion per subject
ranged between 0.05 mm and 0.25 mm.  A few spikes in rela-
tive motion were found in three subjects exceeding 3 mm,  but
overall, less than 5% of the data contained motion greater than
1 mm.  MCFLIRT was  used for motion correction (Jenkinson et al.,
2002). Next, brain extraction, registration of functional to non-
linearly registered anatomical data, spatial smoothing using SUSAN
(Smith and Brady, 1997) with FWHM of 5 mm,  high pass ﬁlter-
ing of 0.008 Hz, and normalization were performed. Individual and
group-level (mixed-effects) analyses were run using FSL to gener-
ate parameter estimates (PE) for Reward and Neutral conditions for
each of the cue, preparation, and saccade phases. Analyses included
only correct AS trials. Nuisance regressors included the six motion
regressors used in motion correction, and the convolved hemo-
dynamic response from trials that either resulted in an incorrect
response or trials that could not be rated due to missing eye-
tracking data (e.g., signal loss during tracking).
Analyses focused on a set of a priori regions of interest (ROIs)
known to be involved in antisaccade performance (Luna et al.,
2001; Velanova et al., 2008, 2009; Geier et al., 2010; Jamadar et al.,
2013) and in reward processing (i.e., amygdala, orbitofrontal cortex,
vmPFC, and striatum) (see Appendix A for details on ROI  location
and volume). Antisaccade-related ROIs were drawn with a 10 mm
or 7 mm (pre-supplementary motor area [preSMA], SEF) sphere
surrounding the peak voxel of the associated cluster identiﬁed by
neurosynth (www.Neurosynth.org) using the name of each ROI as
a keyword. One exception to this was  the ROI for posterior parietal
cortex, which used the term “preparatory”, as this term provided a
closer ﬁt to activations from prior antisaccade studies. The resulting
z-statistic images for these ROIs were then corrected for multiple
comparisons using false discovery rate correction with a q-value
of 0.05. We  also ran whole-brain analyses, but since whole-brain
analyses did not identify clusters of activation beyond the a priori
ROIs, we  report only the ROI results.
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Table  2
Behavioral results for reward and neutral antisaccade trials (N = 14).
Neutral condition Reward condition t-test
Mean (SD) Mean (SD)
Error rate (%) 32.7 (22.6) 18.0 (13.7) 4.3, df = 13, p = .001
Latency of AS errors (ms) 374.1 (51.6)a 365.3 (70.7) 0.9, df = 12, p = .4
Latency of correct ASs (ms) 437.5 (63.5) 434.9 (49.7) 0.2, df = 13, p = .9
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gender, number of days since last marijuana use prior to scan, and
baseline marijuana symptom count) indicated no signiﬁcant asso-
ciations between ROI activation and 6-month marijuana symptom
count (Table 3). By contrast, in the reward condition, activation
Table 3
Partial correlations: fMRI rewarded antisaccade task ROI activation during prepara-
tion phase and marijuana symptom count at 6-month follow-up.
Region of Interest Neutral Reward Reward > neutral
Amygdala R .10 −.76* −.57
Amygdala L .16 −.79** −.78**
Caudate R −.03 −.67 −.62
Caudate L .00 −.68 −.70
nAcc R −.23 −.92** −.62
nAcc L −.10 −.93** −.74*
OFC R .24 −.67 −.68
OFC L .19 −.60 −.67
Putamen R .05 −.90** −.75*
Putamen L .09 −.86** −.75*
vmPFC −.07 −.54 −.41
dACC sphere .36 −.30 −.51
dlPFC L sphere −.08 −.63 −.37
dlPFC R sphere .07 −.55 −.41
FEF L sphere .22 −.52 −.61
FEF R sphere .15 −.68 −.63
PPC L sphere −.16 −.62 −.47
PPC R sphere .07 −.42 −.38
preSMA sphere .06 −.60 −.64
SEF sphere −.16 −.85** −.55
vlPFC L sphere .11 −.83** −.66
vlPFC R sphere .46 −.69 −.75*
Note: N = 14.
The partial correlations marked as statistically signiﬁcant in the table also were
identiﬁed as signiﬁcant using false discovery rate correction with a q-value of 0.05.
6-month marijuana symptom count was log transformed to normalize the distri-
bution.
Covariates: age, gender, number of days since last marijuana use prior to scan
(square root transform), baseline marijuana symptom count.
R = right; L = left; nACC = nucleus accumbens; OFC = orbitofrontal cortex;
vmPFC = ventromedial prefrontal cortex; dACC = dorsal anterior cingulate;ote: AS = antisaccade, ms  = millisecond, df = degrees of freedom.
a n = 13 (1 subject had division by 0).
Parameter estimates, representing mean ROI activation, for
eward and neutral conditions, for each of the three phases, were
xported for analysis in SPSS. Results focus on the preparation
hase, given prior research suggesting the importance of response
reparation for effective response inhibition (Geier et al., 2010;
hung et al., 2011; Munoz and Everling, 2004). Substance use data
e.g., 6-month marijuana symptom count, number of days since
ast use of marijuana prior to the scan) were log transformed to
ormalize distributions. Only the bivariate correlation between
lPFC left sphere and 6-month marijuana symptom count was  sta-
istically signiﬁcant (Reward: r = −.65, p < .01; Reward > Neutral:
 = −.53, p < .05). Partial correlations of ROI activation and 6-month
utcomes controlled for age and baseline level of the outcome
ariable, since they were associated with the marijuana outcome
age: r = −.58, p < .05; baseline marijuana symptom count: r = .69,
 < .01). Gender was not associated with outcome (r = .05, p = .87),
ut was included as a covariate due to gender differences in ado-
escent brain development (Lenroot and Giedd, 2010). Number of
ays since last substance was not signiﬁcantly associated with mar-
juana outcome (r = −.39, p = .17), but was included as a covariate
ue to the possible effect of number of days since last substance
se on brain functioning.
We  also ran the partial correlations excluding the 2 cases (one
t a time) with the highest relative motion (note that these two
ases were within the mean relative motion range of 0.05 mm and
.25 mm per subject). Partial correlations with absolute value >70
n the n = 14 sample were robust to exclusion of these two cases (i.e.,
artial correlations with absolute value >70 remained statistically
igniﬁcant at p < .05 when each case was excluded). Thus, we focus
n reporting results for partial correlations with absolute value >70
although partial correlations with absolute value >63 in the n = 14
ample were signiﬁcant at p < .05).
. Results
.1. Change in alcohol and marijuana involvement over 6-month
ollow-up
Table 1 presents descriptive statistics for alcohol and marijuana
nvolvement at baseline and 6-month follow-up. Paired samples
-tests indicated no signiﬁcant change over 6-month follow-up in
requency of alcohol use (t = −0.73, df = 13, p = .48) or alcohol symp-
om count (t = 0.69, df = 13, p = .50) in this primarily marijuana using
ample. Marijuana use frequency declined, on average, but this
eduction was not statistically signiﬁcant (t = 1.32, df = 13, p = .21).
arijuana symptom count, however, showed a signiﬁcant decrease
ver follow-up (t = 3.00, df = 13, p = .01). Thus, analyses examin-
ng treatment outcome (i.e., change in substance involvement over
ollow-up) focused on marijuana symptom count..2. Antisaccade behavioral performance
Table 2 reports descriptive statistics for behavioral AS perfor-
ance. Across conditions, the average overall correct responserate was 74.9% (SD = 17.9). Paired samples t-test indicated fewer
errors in inhibitory response in the reward versus neutral condition
(t = 4.3, df = 13, p = .001; see Table 2), indicating behavioral sensi-
tivity to the reward condition. There was no signiﬁcant effect of
condition on latency to initiate a correct (t = 0.18, df = 13, p = .86)
or erroneous AS (t = 0.93, df = 12, p = .37), but latency to correct AS
was longer compared to AS errors in both neutral (t = 4.3, df = 12,
p = .001) and reward conditions (t = 3.5, df = 13, p = .001). AS behav-
ioral measures were not correlated with frequency of marijuana
use or marijuana symptom count at 6-month follow-up (p > .2).
3.3. Correlating fMRI preparatory phase ROI activation and
6-month marijuana symptom count
In the neutral condition, partial correlations (controlling for age,dlPFC = dorsolateral prefrontal cortex; FEF = frontal eye ﬁeld; PPC = posterior
parietal cortex; preSMA = presupplementary motor area; SEF = supplementary eye
ﬁeld; vlPFC = ventrolateral prefrontal cortex.
* Partial correlation > 70 and p < .05.
** p < .01.
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n ROIs associated with reward (amygdala, nAcc), executive func-
ioning (left vlPFC sphere), and oculomotor control (SEF sphere,
utamen) were inversely correlated with marijuana symptoms at
-months, controlling for the covariates. In the reward condition,
hose with fewer symptoms at 6-months tended to show greater
ctivation in the ROI relative to baseline ﬁxation, whereas those
ith more symptoms at follow-up tended to show deactivation in
he ROI relative to baseline ﬁxation. Likewise, when contrasting
ctivation in reward versus neutral conditions, greater activation
uring reward versus neutral condition in ROIs associated with
eward (left amygdala, left nAcc), executive function (right vlPFC
phere), and oculomotor control (putamen) were inversely corre-
ated with 6-month marijuana symptom count, controlling for the
ovariates. Inspection of partial correlation plots did not indicate
ndue inﬂuence of outliers (see supplementary ﬁgures).
. Discussion
Results from this preliminary study support hypotheses that,
hen preparing to execute an AS, speciﬁcally during the reward
ue condition, activation in regions associated with cognitive and
culomotor control was inversely correlated with marijuana symp-
om count at 6-month follow-up. Findings highlight the role of
ncentives (“reward cue”) in enhancing or motivating optimal lev-
ls of task-related activation to support effective inhibitory control,
nd indicate that this optimized level of activation during a cog-
itive control task was associated with fewer marijuana-related
roblems among treated adolescents over follow-up. Notably,
outh with more marijuana symptoms over follow-up tended to
how deactivation during the reward condition in ROIs that were
ssociated with treatment outcome. The absence of an associa-
ion between AS behavioral performance and treatment outcome
s consistent with a study of treatment-seeking adults (Brewer
t al., 2008), and suggests the potential utility of a brain-based,
elative to behavioral, indicator in relation to treatment out-
ome.
The absence of an association between ROI activation and treat-
ent outcome during neutral trials suggests the importance of
otivating (by reward cue) optimal performance on a relatively
hallenging cognitive control task, such as antisaccade. Prior work
ith the reward cue AS task indicated that SUD youth do not
enerally lack inhibitory control, and that motivational cues (e.g.,
onetary incentive) can facilitate activation of regions involved
n inhibitory control (Chung et al., 2011). For example, right vlPFC
ctivation has been associated with inhibitory control (Aron and
oldrack, 2006), and speciﬁcally, inhibition of prepotent oculomo-
or responses (Massen, 2004). Results in this sample of treated
outh indicating that greater activation of right vlPFC sphere dur-
ng reward (relative to neutral) trials was associated with lower
arijuana problem severity at follow-up suggest a potential role
or reward in optimizing or motivating activation, particularly
n this ROI, which in turn, was associated with treatment out-
ome.
This study’s ﬁnding that greater activation in regions associ-
ted with cognitive control (e.g., vlPFC) was associated with better
arijuana outcomes in treated adolescents is similar to results
btained using an fMRI Stroop task in cocaine (Brewer et al.,
008) and cannabis dependent adults (Kober et al., 2014). The cur-
ent study extends prior work with treatment seeking adults by
sing an AS task as a different assay of cognitive control, exam-
ning adolescents in community-based substance use treatment,
nd investigating the interplay of reward response and cognitive
ontrol in one task. An important difference between the prior
ork with adults and the current study of adolescents is that
egional activation in cognitive control regions during reward, bute Neuroscience 16 (2015) 93–100
not neutral, trials were associated with adolescent treatment out-
comes. The ﬁnding in the current study that youth with more
marijuana symptoms at follow-up tended to show deactivation in
ROIs that were associated with outcome may  reﬂect, for example,
decreased sensitivity to reward or less efﬁcient brain functioning
during the reward condition. In addition, prior work with treat-
ment seeking adults examined brain response prior to treatment,
whereas in the current study of treated adolescents, brain response
was assessed during or shortly after treatment completion. Nev-
ertheless, research with both treated adults and this pilot study
of treated adolescents suggests that regional activation associated
with cognitive control is associated with subsequent substance use
outcomes.
Notably, the reward cue antisaccade task leverages an indi-
vidual’s sensitivity to reward to motivate or optimize cognitive
control. Consistent with proposed brain-based mechanisms by
which incentives might increase correct AS (Geier et al., 2010;
Geier, 2013), greater activation during reward trials in regions
involved in reward processing (e.g., amygdala, nAcc), oculomotor
control (e.g., putamen, supplementary eye ﬁeld sphere), and execu-
tive functioning (e.g., vlPFC) were associated with fewer marijuana
symptoms at 6-month follow-up in treated adolescents. The asso-
ciation of activation during reward condition in nAcc, but not OFC,
with marijuana outcome also is consistent with reliance on bottom-
up processing of reward during adolescence, in the context of a
relatively immature OFC (Geier, 2013). Adolescent sensitivity to
reward cues, may  bias action to immediate and salient rewards,
such as substance use. However, the use of incentive to support
cognitive control over behavior, for example, in contingency man-
agement interventions (Stanger and Budney, 2010), capitalizes
on adolescent sensitivity to reward to promote positive behavior
change and effortful control over behavior.
As a comparison to ﬁndings with treated adolescents in the cur-
rent study, research on reward response with cocaine dependent
adults in treatment correlated regional activation during reward
processing using an fMRI monetary incentive delay task (MIDT)
with treatment outcome, and found, in general, that reduced
activity in regions involved in reward processing was  associated
with more positive response to behavioral therapy (Jia et al.,
2011). In contrast, results from the current study suggest that
youth with more marijuana symptoms at follow-up showed deac-
tivation during the reward condition in ROIs associated with
treatment outcome. Differences in results across these two stud-
ies may  be due, in part, to differences in the role of reward in
the two tasks (i.e., use of reward to enhance cognitive control
versus response to monetary reward), differences in sample age
(and brain development in adolescents versus adults), primary
substance of abuse, and severity and duration of substance use.
Importantly, with the rewarded antisaccade task, we were able to
assess sensitivity to reward, inhibitory control, and their interplay
(i.e., the use of reward to optimize inhibitory control) in a single
task.
In the reward cue AS task, sensitivity to reward cue was used
to increase top-down or executive cognitive control in inhibiting a
prepotent response (saccade). The incentive used in this study was
relatively small ($10 total upon task completion), and no feedback
was provided to participants on whether an incentive was  earned
for correct antisaccade performance on a given trial, yet reward
cue enhanced behavioral AS performance and inﬂuenced associ-
ated brain activation in predicted ways. Motivational factors that
enhance inhibitory control may  take different forms. For exam-
ple, a study of adolescent marijuana users found that motivation
in the form of hearing and reading “change talk” (statements sup-
portive of positive behavior change) during exposure to marijuana
cues activated brain areas related to response inhibition (e.g., infe-
rior frontal gyrus), and that greater activation in these regions was
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ssociated with better 1-month outcomes (Feldstein Ewing et al.,
013). The potential effect of motivational factors in enhancing
nhibitory control suggest, for example, that proximal reminders
f incentive structure in a contingency management intervention
Stanger and Budney, 2010) or booster motivational interview ses-
ions could help to prime inhibitory control among SUD youth.
Study limitations warrant comment. Generalizability of results
s limited to youth recruited from community-based outpatient
ubstance use treatment, most of whom were male and White,
nd primarily in treatment for marijuana use. This preliminary
tudy analyzed a small sample of youth in substance use treat-
ent. The small sample size and limited number of females
recluded the ability to examine possible differences by sex.
lthough moderate to large effects were detected in hypothe-
ized directions, and analyses included covariates, results need
o be interpreted in the context of small sample size. Further, a
elatively large number of ROIs was tested, and although false
iscovery rate was considered, replication is needed. Although
oth marijuana frequency and abuse/dependence symptom count
eclined over follow-up, only the reduction in marijuana symp-
om count was statistically signiﬁcant, which may  reﬂect limited
ample size. However, similar results regarding alcohol and mari-
uana outcomes have been obtained in other research on adolescent
reatment outcomes (Arias et al., 2014). Self-report of substance use
nd substance-related problems may  be subject to bias, and bio-
hemical veriﬁcation of substance use was not conducted, although
rocedures to maximize validity (e.g., assurance of conﬁdential-
ty) were used. fMRI data were not collected prior to initiating
reatment, such that cognitive functioning at the time of the
ppendix A. Regions of interest for rewarded antisaccade task anal
Region of interest Source MNI coordin
x y 
Amygdala R Atlas 
Amygdala L Atlas 
Caudate R Atlas 
Caudate L Atlas 
nAcc R Atlas 
nAcc  L Atlas 
OFC  R Atlas 
OFC  L Atlas 
Putamen R Atlas 
Putamen L Atlas 
vmPFC Atlas 
dACC  sphere Coordinate 0 22 
dlPFC L sphere Coordinate −42 38 
dlPFC R sphere Coordinate 40 40 
FEF  L sphere Coordinate −26 −6 
FEF  R sphere Coordinate 26 −6 
PPC  L sphere Coordinate −28 −64 
PPC  R sphere Coordinate 30 −62 
preSMA sphere Coordinate 0 6 
SEF  sphere Coordinate 0 0 
vlPFC L sphere Coordinate −48 36 
vlPFC R sphere Coordinate 48 36 
ote: Atlas = Harvard-Oxford Anatomical Atlas; R = right; L = left; nACC = nucleus accumben
nterior cingulate; dlPFC = dorsolateral prefrontal cortex; FEF = frontal eye ﬁeld; PPC = post
ye  ﬁeld; vlPFC = ventrolateral prefrontal cortex.e Neuroscience 16 (2015) 93–100 99
scan, which was associated with treatment outcome, could reﬂect,
for example, effects of treatment or abstinence from substance
use.
5. Conclusions
This preliminary study identiﬁed a potential neurobiological
marker that was associated with adolescent substance use treat-
ment outcome. As a next step, research in a larger adolescent
sample that examines the temporal ordering of regional activation
(e.g., reward-related ROIs inﬂuencing oculomotor control regions)
is needed to test a mechanistic model by which incentives and
other motivational factors (e.g., change talk) acutely enhance cog-
nitive control, which could ultimately inform the development
of neuroscience-informed interventions that aim to strengthen
cognitive control. Further research is needed to probe the use of
adolescent sensitivity to reward (bottom-up processing) to prime
or enhance top-down cognitive control over behavior to improve
youth treatment outcomes.
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ates Radius (mm) Number of voxels
z
434
390
675
632
110
119
1444
1650
1011
979
1011
30 10 515
28 10 515
28 10 515
52 10 515
52 10 515
48 10 515
46 10 515
58 7 179
68 7 179
−4 10 515
−6 10 515
s; OFC = orbitofrontal cortex; vmPFC = ventromedial prefrontal cortex; dACC = dorsal
erior parietal cortex; preSMA = presupplementary motor area; SEF = supplementary
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ppendix B. Supplementary data
Supplementary data associated with this article can be found, in
he online version, at http://dx.doi.org/10.1016/j.dcn.2015.05.004
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